Literature DB >> 26447669

The Fontan circulation and the liver: A magnetic resonance diffusion-weighted imaging study.

Djoeke Wolff1, Joost P van Melle2, Hildebrand Dijkstra3, Beatrijs Bartelds4, Tineke P Willems3, Hans Hillege5, Aad P van den Berg6, Tjark Ebels7, Paul E Sijens3, Rolf M F Berger4.   

Abstract

BACKGROUND: Patients with a Fontan circulation tend to develop liver fibrosis, liver cirrhosis and even hepatocellular carcinoma. The aim of this study is to use the magnetic resonance technique diffusing-weighted imaging (DWI) for detecting liver fibrosis/cirrhosis in Fontan patients and to establish whether DWI results are associated with functional aspects of the Fontan circulation.
METHODS: In a cross-sectional study, 59 Fontan patients were evaluated by liver DWI. The association between apparent diffusion coefficients (ADC) and patient characteristics, laboratory measurements and functional aspects of the Fontan circulation (NYHA class, maximum oxygen uptake during exercise and cardiac index) was assessed.
RESULTS: Liver ADC values were low (0.82×10(-3)±0.11×10(-3) mm2/s) compared with literature values for healthy volunteers and correlated negatively with calculated liver fibrosis/cirrhosis scores (Fib-4 score, p=0.019; AST/ALT ratio, p=0.009) and gamma-glutamyl transferase (p=0.001). Furthermore, ADC values correlated negatively with follow-up duration (p<0.001) and positively with cardiac index (p=0.019). No correlation between ADC values and exercise tests was found. In multivariable analysis, the ADC values were independently correlated with follow-up duration after Fontan completion.
CONCLUSIONS: The results of the current study suggest that progressive liver damage due to chronic congestion and potential hypoperfusion is reflected in the liver ADC values in Fontan patients. This study highlights that liver damage in the context of the Fontan circulation might be far more common than previously thought, and that the implementation of liver assessment in the routine follow-up of Fontan patients is recommendable.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fontan procedure; Liver; Magnetic resonance imaging; Risk factors

Mesh:

Year:  2015        PMID: 26447669     DOI: 10.1016/j.ijcard.2015.09.088

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Assessment of Advanced Liver Fibrosis and the Risk for Hepatic Decompensation in Patients With Congestive Hepatopathy.

Authors:  Alexander Lemmer; Lisa B VanWagner; Daniel Ganger
Journal:  Hepatology       Date:  2018-09-22       Impact factor: 17.425

2.  A computational study of the Fontan circulation with fenestration or hepatic vein exclusion.

Authors:  Charles Puelz; Sebastián Acosta; Béatrice Rivière; Daniel J Penny; Ken M Brady; Craig G Rusin
Journal:  Comput Biol Med       Date:  2017-08-25       Impact factor: 4.589

Review 3.  Clinical Advancements in the Targeted Therapies against Liver Fibrosis.

Authors:  Ruchi Bansal; Beata Nagórniewicz; Jai Prakash
Journal:  Mediators Inflamm       Date:  2016-11-24       Impact factor: 4.711

4.  Diminished liver microperfusion in Fontan patients: A biexponential DWI study.

Authors:  Hildebrand Dijkstra; Djoeke Wolff; Joost P van Melle; Beatrijs Bartelds; Tineke P Willems; Matthijs Oudkerk; Hans Hillege; Aad P van den Berg; Tjark Ebels; Rolf M F Berger; Paul E Sijens
Journal:  PLoS One       Date:  2017-03-03       Impact factor: 3.240

Review 5.  Abdominal imaging findings in adult patients with Fontan circulation.

Authors:  Tae-Hyung Kim; Hyun Kyung Yang; Hyun-Jung Jang; Shi-Joon Yoo; Korosh Khalili; Tae Kyoung Kim
Journal:  Insights Imaging       Date:  2018-04-05

6.  Spontaneously ruptured hepatocellular carcinoma in Fontan-associated liver disease: A case report.

Authors:  Takahiro Kubo; Yosuke Aihara; Hideto Kawaratani; Tadashi Namisaki; Ryuichi Noguchi; Akira Mitoro; Hitoshi Yoshiji
Journal:  SAGE Open Med Case Rep       Date:  2020-05-06

7.  GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan Circulation.

Authors:  Sophie L Meyer; Djoeke Wolff; Floris-Jan S Ridderbos; Graziella Eshuis; Hans Hillege; Tineke P Willems; Tjark Ebels; Joost P van Melle; Rolf M F Berger
Journal:  J Am Heart Assoc       Date:  2020-05-08       Impact factor: 5.501

8.  Fontan-associated liver disease and hepatocellular carcinoma in adults.

Authors:  Tomomi Kogiso; Katsutoshi Tokushige
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

9.  Potential of Liver T1 Mapping for the Detection of Fontan-associated Liver Disease in Adults.

Authors:  Yumi Shiina; Kei Inai; Ryoko Ohashi; Michinobu Nagao
Journal:  Magn Reson Med Sci       Date:  2020-09-07       Impact factor: 2.471

10.  Persistent Liver Dysfunction in Pediatric Patients After Total Cavopulmonary Connection Surgery.

Authors:  Qipeng Luo; Yuan Jia; Zhanhao Su; Hongbai Wang; Yinan Li; Xie Wu; Qiao Liu; Xiaoguang Liu; Su Yuan; Fuxia Yan
Journal:  Front Cardiovasc Med       Date:  2022-04-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.